Search results
What's driving this multiday rally, plus Jim Cramer's quick takes on 4 stocks
CNBC· 20 hours agoEvery weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable...
Gilgamesh starts subject dosing in major depressive disorder trial
Clinical Trials Arena via Yahoo Finance· 5 days agoThis clinical trial aims to evaluate the safety, tolerability, and...GM-2505, through Phase II...
EyePoint Pharmaceuticals stock target cut, retains Buy rating By Investing.com
Investing.com· 4 hours agoThe reduction follows a significant 43% drop in EyePoint's share value on Monday, which contrasted...
Cannabis stocks surge on reports DEA will approve rescheduling of marijuana as lower-risk drug By...
Investing.com· 7 days ago“We've written many times how the major reason current multiples are depressed is lack of...
'Elon Musk has let us down': Tesla enters its fourth week of layoffs
Quartz· 22 hours agoElon Musk’s “absolutely hardcore” layoffs won’t stop coming as Tesla employees announce their...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 7 days agoIn her tenure the agency so far has challenged two major pharmaceutical mergers, sued a...
At least 25,000 people in the US are starting weight-loss drug Wegovy each week, drugmaker says
CNN via Yahoo Finance· 5 days agoDrugmaker Novo Nordisk said it’s been increasing supply of its sought-after weight-loss drug Wegovy,...
Will DOD need to start producing some medicines to protect troops?
Military Times via Yahoo News· 4 days ago“Most of the time DOD will continue to purchase drugs from the commercial drug market. But there are...
At Neumann University crime lab, police and students work together to solve crimes
CBS News· 15 hours agoNeumann University is collaborating with the Delaware County District Attorney's Office and the...
The Only Major Actors Still Alive From Matlock - SlashFilm
/Film· 2 days agoThe Kathy Bates-led reboot of "Matlock" may not hit TV screens for a while longer, but in the...